The Journal of mHealth Vol 2 Issue 4 (August) - Page 11

Industry News all device profile has been reduced so the system can be worn discreetly under a patient’s clothing. The effect is that the system feels essentially “invisible” to the wearer, providing a more comfortable trial experience that allows patients to focus entirely on their system’s therapeutic impact during their trial. “When we developed the new Invisible Trial System, we took into account physician and patient feedback that current trial systems were in some cases preventing patients from adequately assessing their therapy,” said Eric S. Fain, M.D., group president of St. Jude Medical. “By providing a more patient-friendly option, we think we can shorten the learning curve related to trial programming devices and allow patients to better assess the potential pain relief they’re receiving from spinal cord stimulation.” The iPod touch controller offers patients a simple, familiar platform to adjust their therapy. An iPad mini tablet is used by the patient’s physician to set the programming parameters. The programmer also displays trial usage data from the EPG and allows the physician to print or email the data in PDF format. Bluetooth wireless technology safely and securely communicates wirelessly between the EPG and patient and physician devices, eliminating the programming trial cable and thus increasing the patient’s comfort. n mHealth Market to Grow at an Impressive CAGR 33.5% between 2015-2020 A new report by Allied Market Research, titled, “Global mHealth Market (Device, Service, Application, Stakeholders and Geography) - Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 2014-2020”, has valued the global mHealth market at $10.5 billion in 2014 and forecasts it to grow at a CAGR of 33.5% during 2015-2020. Other key findings from the report suggest that blood pressure monitors hold the largest share in the global mHealth device market, followed by blood glucose monitors and cardiac monitors. Geographically, it was observed that the North American region retained a leading position in the overall mHealth market throughout the analysis period. The report also highlights the current state of the market identifying the opportunities and risks for development. Advanced mobile and wireless technologies are recognised for their role in transforming the face of healthcare services across the globe and driving growth in the mHealth market. Moreover, the continued growth in coverage of mobile cellular networks, rapid advances in mobile technologies & applications, increasing lifestyle diseases and growing awareness among patient population in emerging economies, are some of the key factors fostering global market expansion. On the contrary the market faces certain difficulties. Device accuracy, technology infancy in middle and lower income economies, weak reimbursement coverage, uncertainty in government regulations in certain regions, and low adoption among ageing population is hampering the market growth to a certain extent. It is observed that a major proportion of the mHealth devices market (~71%) is collectively commanded by BP monitors, blood glucose monitors and cardiac monitors. The reasoning behind this market share is attributed to the increased affordability of mobile compatible devices, integration of innovative technologies in monitoring devices and the increase of lifestyle disease such as diabetes, stroke, and COPD. Within the market for mHealth services, diagnostic, monitoring and treatment services collectively account for about 74% of the market. The report identifies North America  and  Europe  as the two largest markets for mHealth. Collectively they account for 67% of the market revenue in 2014. It also suggests that they are expected to remain as the leading global markets throughout the forecast period. Early adoption of innovative technology, large patient population and high capacity to pay for services are some of the key factors responsible for the growth of mHealth market in these regions. However, the market outlook across developing economies appears favourable owing to the increasing awareness of chronic diseases, supportive government regulations and increased healthcare W